Antidiabetic PowerPoint PPT Presentations

antidiabetic agents ji sl va

Lecture 14 Chapter 46 Antidiabetic Drugs Antidiabetic Drugs Drugs used to control diabetes mellitus - a chronic disease that affects carbohydrate metabolism 2 groups ...

SAR Antidiabetic Agents X = O, S, or N

DM is a chronic metabolic disorder characterised by a high blood glucose ... in turn, results in dehydration, thirst and increased drinking polydipsia. ...

The AntiDiabetic Market is segmented based on Product, Administration Route, Patient Age-group and into Insulin segment and Drug segment based on product. Based on Product, the market is subdivided into Insulin Products and Drugs while based on Route of Administration, it is divided into Syringe/Pen, Insulin Pump, Intravenous Infusion and Oral.

Diabetic patients take Insulin and/or other oral hypoglycemic and antihyperglycemic drugs to control their blood sugar levels. Along with antidiabetic medicines they may take drugs such as OTC medicines, prescription medicines, etc.to treat other illnesses which may interact with them. Drug interactions of Insulin with other drugs like Fluoroquinolones, Betablockers, Aspirin, Thiazolidinediones, Antipsychotics, Androgens, Antimalarials and Orlistat are dealt in this presentation. The interactions of Insulin with Complementary and alternative medicines (CAM) such as Bitter melon, Ginkgo, Ginseng, Gymnema, Licorice and Fenugreek with smoking and with alcohol are also dealt in this presentation.

Oral Antidiabetic Drugs, also known as oral hypoglycemic agents or oral antihyperglycemic agents, are medications used to treat diabetes mellitus type 2. Unlike diabetes mellitus type 1, where insulin replacement therapy is necessary, type 2 diabetes can often be managed initially with lifestyle changes, such as diet and exercise, along with oral antidiabetic medications. The main goal of these drugs is to lower and control blood glucose levels in individuals with type 2 diabetes, as high blood sugar levels can lead to various complications over time. Click here for more information: https://www.htfmarketintelligence.com/report/global-oral-antidiabetic-drugs-market

Antidiabetics Market size is valued at $ 61.5Bn by 2019 and is anticipated to grow at a CAGR of 4.6% during the forecast period 2020-2025.

Drug interactions of Incretin mimetics (Exenatide) with other drugs like Warfarin, Digoxin, Paracetamol, Antibacterials, Thyroid hormones, Danazol and ACE inhibitors are dealt in this presentation. The interactions of Amylin analogue (Pramlintide) with other drugs such as Alpha glucosidase inhibitors, Danazol, ACE inhibitors, Thyroid hormones, Paracetamol and Antimuscarinics are also dealt in this presentation.

The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Antidiabetic Sulphonylureas industry; 3.) the North American Antidiabetic Sulphonylureas industry; 4.) the European Antidiabetic Sulphonylureas industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

The report firstly introduced the Antidiabetic Biguanides basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

Antidiabetics Market Size By Product, By Application, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

The report firstly introduced the Antidiabetic Thiazolidinediones basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The Global And China Antidiabetics Drug Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Antidiabetics Drug industry.

Antidiabetics Market size was valued over USD 49.5 billion in 2016 and is expected to witness more than 10.5% CAGR from 2017 to 2024. Get more details @ https://goo.gl/UNqMWV

¢ Drug interactions of Meglitinides (Repaglinide & Nateglinide) are dealt in this presentation. ¢ Repaglinide is metabolized by the CYP3A4 and CYP2C8 and hence it interacts with Gemfibrozil, Azole antifungals, Dabrafenib, Montelukast, Macrolide antibiotics and Rifampicin. ¢ Nateglinide is metabolized by CYP2C9 (70%) and CYP3A4 (30%) and it interacts with Amiodarone and Macrolide antibiotics. It also interacts with NSAIDs, MAOIs, Trandolapril, Non selective beta blockers Thiazide diuretics, Corticosteroids, Danazol, Sympathomimetics, Phenytoin and St.John’s wort.

Sulfonylureas may interact with Azole antifungals (Fluconazole), Fibrates (Gemfibrozil), Sulphonamides (Trimethoprim), Macrolide antibiotics (Erythromycin), Rifampin, Bosentan, Antacids, Alpha glucosidase inhibitors, Bile-acid binding resins (Colestyramine, colestipol, and colesevelam), ACE inhibitors, Allopurinol and Alcohol.

To Know More: https://www.24marketreports.com/life-sciences/global-oral-antidiabetic-drugs-2018-2023-474 Diabetes mellitus is a group of a metabolic disorder caused when the body is unable to produce required quantity of Insulin. Insulin is a hormone secreted by beta cells of the islet of Langerhans of the pancreas. Various symptoms associated with diabetes disorder include recurrent urination, increased thirst, and hunger. Diabetes can cause much chronic complication if left untreated. Some of them include acute complications like diabetic ketoacidosis, chronic kidney failure, foot ulcers, and damage to the eyes.

Oral Antidiabetic (OAD) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Antidiabetic (OAD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

According to a research report by Global Market Insights Inc., the global antidiabetics market would register a CAGR of 10.7% through the forecast timeframe. The market was valued at more than $65.5 billion in 2019. The increasing diabetic and obese population across the globe is slated to impel the antidiabetics market growth over the coming years. Request sample copy of this Report @ https://www.gminsights.com/request-sample/detail/504

Antidiabetics Market size was valued over USD 49.5 billion in 2016 and is expected to witness more than 10.5% CAGR from 2017 to 2024. Get more details @ https://goo.gl/UNqMWV

For more details visit @ http://bit.ly/2jTItYg Antidiabetics Market to be dominated by some notable industry participants includingTakeda, Merck, Boehringer Ingelheim, Oramed, Pfizer, Novo Nordisk, Eli Lilly and Sanofi Aventis.

DPP 4 Inhibitors interact with CYP3A4 inducers, CYP3A4 inhibitors and P-Glycoproteins inhibitors.

Alpha-glucosidase inhibitors interact with drugs such as Digoxin, Warfarin, Sulfonylureas, Neomycin, Guar gum, Pancreatin, Amylase, Activated charcoal, Antimuscarinics, Paracetamol and Nifedipine.

Get more details @ http://bit.ly/2t2aMfX Rising diabetes incidences, large unmet medical needs, and extensive R&D activities to launch new antidiabetic drugs including Glucagon like peptide 1 (GLP-1) agonist and Dipeptidyl peptidase - IV will promote other antidiabetics market growth.

The report firstly introduced the Antidiabetic SGLT-2 Inhibitor basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc.

Get more details @ http://bit.ly/2t2aMfX Some of the major players dominating global antidiabetics market are Novo Nordisk, Eli Lilly and Sanofi. Extensive product portfolio and rising R&D investment for producing innovative and pipeline products are the major strategies adopted by these players to maintain their market share.

Mortality risk associated with different classes of antidiabetic agents in high-exposure patients 95% CI Relative risk Drug 1.0-4.7 2.1 First-generation sulfonylureas ...

To read the complete report at: http://www.marketreportsonindia.com/life-sciences-market-research-reports-3787/diabetes-insulin-diagnostic-india.html Market reports on India presents the latest report on “Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics”The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India.

Value of SMBG in Type 2 diabetes taking oral antidiabetic agents LifeScan Reimbursement Team September 01, 2006 Version 1.0 AW 088-723A AW 089-677A

The global antidiabetics market was valued at USD 41,305.7 million in 2013 and is expected to grow at a CAGR of more than 9.5% during the forecast period.

Disease Burden and Intensity of Antidiabetic Drug Use by Medicare Beneficiaries with Diabetes: Will Part D Make a Difference?

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor g (PPARg) Jurgen Lehmann et al., 1995, Journal of ...

... factors. 3 subtypes. PPAR a -liver and skeletal muscle ... Kidney cells from male adult African green monkey. PPAR cDNA placed in expression vector (pSG5) ...

Diabetic Therapy Market by Product [Injectables (Insulin, Glucagon-like Peptide-1 (GLP-1) Receptor Agonists, and Amylinomimetic Drugs) and Oral-antidiabetic Drugs (OAD) (Biguanides, Sulfonylureas, Thiazolidinediones, Alpha-glucosidase Inhibitors, Dipeptidyl Peptidase IV (DPP-4) Inhibitors, Meglitinides, and Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors)], and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

... Effect In patients with type 2 diabetes who had inadequate glycaemic control despite high-dose insulin plus oral antidiabetic drugs that act via insulin ...

... such as repaglinide are a relatively new class of oral antidiabetic and increase insulin secretion by binding to the sulphonylurea binding site.

Anti-ulcerants. Cough mixtures. Impotence therapy. Anti-Retrovirals. Cholesterol lowering drugs ... Anti-tuberculosis. Antibiotics. Contraceptives. Antidiabetic ...

Glycogen phosphorylase inhibitors as potential antidiabetic drugs ... Dr. Virginia L. Rath, Dept. of Explor. Med. Sciences, Pfizer Inc., USA ...

Combination of drugs with similar effect. Low therapeutic index ... Peroral antidiabetics. Peroral anticoagulants. Heart glykosides. Antiepileptics. Antimanics ...

Table 4 Effects of diabetes treatment with oral antidiabetic drugs or insulin on hepatocellular lipid content, whole-body and hepatic insulin sensitivity, plasma free ...

Market Reports on India presents the latest report on “Indian Diabetes Market Report Oral Antidiabetics, Insulin and Diagnostics”. http://www.marketreportsonindia.com/life-sciences-market-research-reports-3787/indian-diabetes-patients-prevalence-oral-antidiabetics-insulin-diagnostics.html . The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in India.

Antidiabetics Market Size – USD 61.16 billion in 2018, Market Growth - CAGR of 10.2%, Market Trends –Technological advancement along with increasing incidences of diabetics.

... pump inhibitors 66699.9 58004.85 NSAID 43014.1 42778.9 Antiasthmatic drugs 37435.85 31818.25 Antidepressant drugs 26372.8 28434.95 Antidiabetics 32007.15 ...

If you are looking or search pharmaceutical drop shipping companies in India. Generic Medicine Dropshipper is here. We provide pharmaceutical drop shipping services all all worlds. We serve all type medicine or drug products, included: Pain Relief, Antibiotics, Antidepressants, Weight Loss, Skin Care, Antidiabetic, Antiviral, Cholesterol and many more FDA approved medical products.

Global Market Estimates is a market research and business consulting company who has proven track record in serving Fortune 500 companies. Request for a sample copy of the ‘Oral Anti Diabetic Drug Market’ report @: https://www.globalmarketestimates.com/oral-antidiabetic-drug-market/

The researcher assessing the Antidiabetics market dive deep to unearth intangible facts related to the key restraints, opportunities, and threats expected to shape the progress of the industry during the forecast period, 2019 - 2026.

This report studies the market trends, demographical breakup, diagnosis and treatment, and growth of the Canada diabetes market. Read full report @ http://www.imarcgroup.com/canada-diabetes-market-report-forecast-2011-2016

This report highlights the market trends, epidemiology demographical breakup, diagnosis and treatment and the key players in the Spain diabetes market. Read full report @ http://www.imarcgroup.com/spain-diabetes-market

FenuLean® is a debitterized and defatted Fenugreek seed component (Trigonella foenum-graecum). Fenugreek seeds are quite bitter and are not suitable for a worldwide palate.

If you are searching for the best Neuropsychiatrist Pharma Franchise in India then Lifecare Neuro is the right choice for you. To get the nueropsychiatrist pharma franchise you should choose a franchise first and get the necessary documents to start the process. For more details contact us.

This report analyses the Germany diabetes market and serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Germany diabetes market in the country. Read full report @ http://www.imarcgroup.com/germany-diabetes-market

A minimum of 12 small excrescences forms in the ovaries. These excrescences aren't large enough to spark ovulation.

A minimum of 12 small excrescences forms in the ovaries. These excrescences aren't large enough to spark ovulation.

Obesity and changing lifestyle have led to an increase in the occurrence of diabetes among the young and old in US. This report highlights the market trends, epidemiology demographical breakup, diagnosis and treatment and the key players in the US diabetes market. Readfull report @ http://www.imarcgroup.com/US-diabetes-market

This report provides an insight into the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Brazil diabetes market. Read full report @ http://www.imarcgroup.com/brazil-diabetes-market-report-forecast-2011-2016